Zurcher Kantonalbank (Zurich Cantonalbank) Aerie Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	BUY	$12.0 - $16.13 $17,148 - $23,049	1,429 Added 39.68%	5,030 $74,000
Q1 2020 May 06, 2020	BUY	$11.84 - $25.52 $15,995 - $34,477	1,351 Added 60.04%	3,601 $49,000
Q1 2019 Apr 29, 2019	SELL	$36.32 - $49.25 $18,268 - $24,772	-503 Reduced 18.27%	2,250 $107,000
Q4 2018 Jan 25, 2019	BUY	$33.0 - $60.04 $16,995 - $30,920	515 Added 23.01%	2,753 $99,000
Q2 2018 Aug 06, 2018	BUY	$47.85 - $70.45 $26,652 - $39,240	557 Added 33.14%	2,238 $151,000
Q4 2017 Jan 31, 2018	BUY	$50.85 - $65.1 $17,289 - $22,133	340 Added 25.35%	1,681 $100,000
Q3 2017 Nov 08, 2017	BUY	$48.6 - $60.1 $65,172 - $80,594	1,341	1,341 $65,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account